Stephen Willey
Stock Analyst at Stifel Nicolaus
(4.11)
# 1,549
Out of 4,396 analysts
576
Total ratings
42.8%
Success rate
6.1%
Average return
Main Sectors:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNDX Syndax Pharmaceuticals | Maintained: Buy | $46 | $16.96 | +171.23% | 6 | Jun 3, 2026 | |
| IRON Disc Medicine | Maintained: Buy | $111 | $65.80 | +68.69% | 10 | Jun 3, 2026 | |
| INCY Incyte | Maintained: Buy | $123 | $100.64 | +22.22% | 37 | Jun 1, 2026 | |
| CBIO Crescent Biopharma | Maintained: Buy | $30 | $17.28 | +73.61% | 16 | Jun 1, 2026 | |
| CMPX Compass Therapeutics | Maintained: Buy | $6 | $2.02 | +197.03% | 13 | Jun 1, 2026 | |
| CELC Celcuity | Rated: Buy | $150 → $175 | $87.43 | +100.16% | 9 | May 15, 2026 | |
| NRIX Nurix Therapeutics | Maintained: Buy | $34 | $15.64 | +117.39% | 28 | May 15, 2026 | |
| MGNX MacroGenics | Maintained: Hold | $4 | $3.88 | +3.09% | 34 | May 14, 2026 | |
| NKTX Nkarta | Maintained: Buy | $11 | $2.40 | +358.33% | 25 | May 13, 2026 | |
| ABCL AbCellera Biologics | Rated: Buy | $7 → $8 | $5.42 | +47.60% | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 → $46 | $20.10 | +128.86% | 14 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $208 → $200 | $94.17 | +112.38% | 29 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $47 | $51.74 | -9.16% | 54 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $13.51 | +181.27% | 4 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 | $23.93 | +96.41% | 31 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.69 | +373.37% | 5 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $13.29 | +200.98% | 24 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 | $5.38 | +215.99% | 6 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.28 | +294.74% | 10 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $7.5 | $3.71 | +102.16% | 17 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $6.05 | +362.81% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $20 | $4.72 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.13 | n/a | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $29.08 | n/a | 15 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.04 | n/a | 10 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $6 | $0.7549 | n/a | 17 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $8.99 | n/a | 6 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $5 | $1.02 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $1 | $1.09 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $27 | $2.74 | n/a | 4 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $1.88 | n/a | 11 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $21 | $51.21 | n/a | 5 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $160 | $4.04 | n/a | 1 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $95 → $125 | $292.16 | n/a | 6 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $109 → $114 | $56.55 | n/a | 14 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $48 | $73.54 | n/a | 13 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $16 | $22.33 | n/a | 13 | Apr 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2.5 | $0.0001 | n/a | 3 | Sep 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $26 | $10.85 | n/a | 2 | Apr 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $2.85 | n/a | 1 | Feb 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $5.86 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $232.04 | n/a | 1 | May 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.48 | n/a | 5 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $101 | - | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $26 | $4.24 | n/a | 3 | Nov 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $7 | $30.08 | n/a | 2 | Apr 8, 2013 |
Syndax Pharmaceuticals
Jun 3, 2026
Maintained: Buy
Price Target: $46
Current: $16.96
Upside: +171.23%
Disc Medicine
Jun 3, 2026
Maintained: Buy
Price Target: $111
Current: $65.80
Upside: +68.69%
Incyte
Jun 1, 2026
Maintained: Buy
Price Target: $123
Current: $100.64
Upside: +22.22%
Crescent Biopharma
Jun 1, 2026
Maintained: Buy
Price Target: $30
Current: $17.28
Upside: +73.61%
Compass Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $6
Current: $2.02
Upside: +197.03%
Celcuity
May 15, 2026
Rated: Buy
Price Target: $150 → $175
Current: $87.43
Upside: +100.16%
Nurix Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $34
Current: $15.64
Upside: +117.39%
MacroGenics
May 14, 2026
Maintained: Hold
Price Target: $4
Current: $3.88
Upside: +3.09%
Nkarta
May 13, 2026
Maintained: Buy
Price Target: $11
Current: $2.40
Upside: +358.33%
AbCellera Biologics
May 12, 2026
Rated: Buy
Price Target: $7 → $8
Current: $5.42
Upside: +47.60%
May 12, 2026
Maintained: Buy
Price Target: $48 → $46
Current: $20.10
Upside: +128.86%
May 8, 2026
Maintained: Buy
Price Target: $208 → $200
Current: $94.17
Upside: +112.38%
May 6, 2026
Rated: Hold
Price Target: $47
Current: $51.74
Upside: -9.16%
Apr 28, 2026
Maintained: Buy
Price Target: $38
Current: $13.51
Upside: +181.27%
Apr 22, 2026
Maintained: Buy
Price Target: $47
Current: $23.93
Upside: +96.41%
Apr 22, 2026
Maintained: Buy
Price Target: $8
Current: $1.69
Upside: +373.37%
Apr 8, 2026
Maintained: Buy
Price Target: $40
Current: $13.29
Upside: +200.98%
Mar 18, 2026
Maintained: Buy
Price Target: $17
Current: $5.38
Upside: +215.99%
Mar 5, 2026
Reiterated: Buy
Price Target: $9
Current: $2.28
Upside: +294.74%
Nov 5, 2025
Reiterated: Buy
Price Target: $9 → $7.5
Current: $3.71
Upside: +102.16%
Jun 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $6.05
Upside: +362.81%
May 13, 2025
Reiterated: Hold
Price Target: $25 → $20
Current: $4.72
Upside: n/a
Mar 12, 2025
Maintained: Buy
Price Target: $4
Current: $1.13
Upside: n/a
Nov 15, 2024
Maintained: Buy
Price Target: $4
Current: $29.08
Upside: n/a
Nov 6, 2024
Maintained: Buy
Price Target: $4
Current: $2.04
Upside: n/a
May 14, 2024
Maintained: Hold
Price Target: $7 → $6
Current: $0.7549
Upside: n/a
May 13, 2022
Maintained: Hold
Price Target: $6 → $5
Current: $8.99
Upside: n/a
May 13, 2022
Maintained: Hold
Price Target: $9 → $5
Current: $1.02
Upside: n/a
May 11, 2022
Maintained: Hold
Price Target: $3 → $1
Current: $1.09
Upside: n/a
Mar 12, 2021
Maintained: Buy
Price Target: $25 → $27
Current: $2.74
Upside: n/a
Mar 11, 2021
Maintained: Hold
Price Target: $6
Current: $1.88
Upside: n/a
Mar 29, 2019
Maintained: Buy
Price Target: $18 → $21
Current: $51.21
Upside: n/a
Mar 14, 2019
Maintained: Hold
Price Target: $160
Current: $4.04
Upside: n/a
Aug 6, 2018
Upgraded: Buy
Price Target: $95 → $125
Current: $292.16
Upside: n/a
Aug 6, 2018
Reiterated: Buy
Price Target: $109 → $114
Current: $56.55
Upside: n/a
Aug 6, 2018
Reiterated: Hold
Price Target: $55 → $48
Current: $73.54
Upside: n/a
Apr 27, 2018
Maintained: Hold
Price Target: $17 → $16
Current: $22.33
Upside: n/a
Sep 26, 2017
Downgraded: Hold
Price Target: $13 → $2.5
Current: $0.0001
Upside: n/a
Apr 4, 2017
Reiterated: Buy
Price Target: $20 → $26
Current: $10.85
Upside: n/a
Feb 2, 2017
Reiterated: Buy
Price Target: $24
Current: $2.85
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $23
Current: $5.86
Upside: n/a
May 31, 2016
Reiterated: Buy
Price Target: $200
Current: $232.04
Upside: n/a
Dec 2, 2015
Downgraded: Hold
Price Target: n/a
Current: $5.48
Upside: n/a
Mar 31, 2015
Downgraded: Hold
Price Target: $101
Current: -
Upside: n/a
Nov 7, 2014
Reiterated: Buy
Price Target: $31 → $26
Current: $4.24
Upside: n/a
Apr 8, 2013
Reiterated: Buy
Price Target: $11 → $7
Current: $30.08
Upside: n/a